|Articles|March 7, 2019
European Medical Device Company Signs Agreement to Use OmniComm’s TrialMaster
Advertisement
OmniComm Systems, Inc., a global provider of clniical data management technology, announced that a major European medical device company specializing in ophthalmology has signed a three-year agreement to use it's TrialMaster EDC. The medical device company will use TrialMaster to build and manage multiple clinical studies.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Generative AI Transforms Clinical Study Report Development
2
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
3
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
4
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
5